2025 Annual Meeting | S27 - General Neurology 2
Program Materials Program Evaluations
Liliana A. Ramirez-Gomez, MD, FAAN | The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH. |
Fatima Traore, MD | Dr. Traore has nothing to disclose. |
Bethany Zanrucha | Bethany Zanrucha has stock in IntraBio. Bethany Zanrucha has stock in Sarepta. |
Janelle Raymond, PhD | Dr. Schafer has received personal compensation for serving as an employee of IntraBio. Dr. Schafer has stock in Amylyx Pharmaceuticals . |
Michael Strupp, MD, DO, FAAN | Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio. |
Tatiana T. Bremova-Ertl, MD, PhD | Dr. Bremova-Ertl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrabio. The institution of Dr. Bremova-Ertl has received research support from InnoSuisse. Dr. Bremova-Ertl has received research support from Baasch-Medicus. |
Ian Billington, PhD | Mr. Billington has received personal compensation for serving as an employee of IntraBio Inc. Mr. Billington has stock in IntraBio Inc. |
Juan Carlos Acevedo Gonzalez, MD | Dr. ACEVEDO GONZALEZ has nothing to disclose. |
Andres Ricaurte, MD | Dr. Ricaurte has nothing to disclose. |
Valentina Velasco | Miss Velasco has nothing to disclose. |
Kiara Torres Tello, Student | Miss Torres Tello has nothing to disclose. |
Gabriel Castellanos, MD | Dr. Castellanos has nothing to disclose. |
Salomón D. Páez, Sr. | Dr. Páez has nothing to disclose. |
Hernando Santamaría, MD | Dr. Santamaría has nothing to disclose. |
Angela L. Genge, MD | Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for pepgen. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa. |
Gary L. Pattee, MD | The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals. |
Gen Sobue, MD | Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited.. |
Masashi Aoki, MD, PhD | Masashi Aoki, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tanabe Mitsubishi. |
Hiide Yoshino, MD | Dr. Yoshino has nothing to disclose. |
Philippe Couratier, PhD | Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Couratier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier . |
Christian Lunetta, MD | Dr. Lunetta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Lunetta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. |
Susanne Petri, MD | Prof. Petri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Petri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer. Prof. Petri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Prof. Petri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Petri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Italfarmaco. Prof. Petri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Prof. Petri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Petri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amylyx. The institution of Prof. Petri has received research support from ALS Research Inc,. The institution of Prof. Petri has received research support from German Neuromuscular Scociety. The institution of Prof. Petri has received research support from Karlheinz Hartmann-Foundation. The institution of Prof. Petri has received research support from Petermax Müller-Foundation. |
Daniel Selness | Mr. Selness has received personal compensation for serving as an employee of Mitsubishi Tanabe. |
Vesna Todorovic, MD | Dr. Todorovic has nothing to disclose. |
Manabu Hirai | Mr. Hirai has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America. |
Alejandro Salah, MD, PhD, MBA, MHA | Dr. Salah has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma. |
Stephen Apple | Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc. |
Arthur Wamil, MD, PhD | Dr. Wamil has received personal compensation for serving as an employee of Mitsubishi Tanabe. |
Alexander Kalin | Alexander Kalin has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.. |
Carlayne E. Jackson, MD, FAAN | Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma America. Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital. |
Yi-Xuan Wang | Dr. Wang has nothing to disclose. |
Jintai Yu | No disclosure on file |
Kendall A. Curtis | Miss Curtis has nothing to disclose. |
Srividya Kottapalli, BS | Miss Kottapalli has nothing to disclose. |
Erica Kemp | Ms. Kemp has nothing to disclose. |
Janet F. Waters, MD, FAAN | An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Haemonetics. An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haemonetics. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Vitalant. An immediate family member of Dr. Waters has received publishing royalties from a publication relating to health care. |
Diego Cadavid, MD, FAAN | Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has stock in Verge Genomics. |
Ines Hoffmann, PhD | Dr. Hoffmann has received personal compensation for serving as an employee of Xencor. Dr. Hoffmann has received personal compensation for serving as an employee of Verge Genomics. Dr. Hoffmann has stock in Xencor. |
Payal Nanavati | No disclosure on file |
Anil Tarachandani, PhD | Dr. Tarachandani has received personal compensation for serving as an employee of Verge Genomics. Dr. Tarachandani has stock in Verge Genomics. |
Irene Choi, PhD | Dr. Choi has received personal compensation for serving as an employee of Verge Genomics. Dr. Choi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Modality AI. Dr. Choi has stock in Nektar Therapeutics. Dr. Choi has stock in Verge Genomics. Dr. Choi has stock in Modality AI. |
Robert H. Scannevin, PhD | No disclosure on file |
William G. Tracewell, PhD | Dr. Tracewell has received personal compensation for serving as an employee of Allucent. |
Paula Sandler | No disclosure on file |
Brian Shook, PhD | Dr. Shook has nothing to disclose. |
Philip Van Damme | The institution of Dr. Van Damme has received research support from CSL Behring. |
Pentti Tienari, MD, PhD | Dr. Tienari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck GmBH. Dr. Tienari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tienari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Tienari has received research support from Helsinki University Hospital. The institution of Dr. Tienari has received research support from Sigrid Juselius Foundation. The institution of Dr. Tienari has received research support from Maze Therapeutics. The institution of Dr. Tienari has received research support from Verge genomics. The institution of Dr. Tienari has received research support from University of Helsinki. The institution of Dr. Tienari has received research support from Private donor. Dr. Tienari has received intellectual property interests from a discovery or technology relating to health care. |
Eino Solje, MD, PhD | Prof. Solje has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. |
Manu Jokela | Manu Jokela has nothing to disclose. |
Colleen O'Connell | Colleen O'Connell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Colleen O'Connell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Colleen O'Connell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Colleen O'Connell has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT PHarma. The institution of Colleen O'Connell has received research support from Biogen. The institution of Colleen O'Connell has received research support from Calico. The institution of Colleen O'Connell has received research support from Praxis Spinal Cord Institute. The institution of Colleen O'Connell has received research support from Verge. Colleen O'Connell has a non-compensated relationship as a Steering Committee with World Rehabilitation Alliance that is relevant to AAN interests or activities. |
Ruben van Eijk, MD, PhD | Dr. van Eijk has nothing to disclose. |
Ashwin Swami, MD | Dr. Swami has nothing to disclose. |
Martin J. Schmidt, PhD | Dr. Schmidt has received personal compensation for serving as an employee of Kypha Inc.. Dr. Schmidt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Verge Genomics. Dr. Schmidt has stock in Kypha Inc. Dr. Schmidt has received intellectual property interests from a discovery or technology relating to health care. |
Leonard H. Van den Berg, MD | The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation. |
Dina Katabi, PhD | Prof. Katabi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J. Prof. Katabi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Katabi has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Cyclerion, Inc. Prof. Katabi has stock in Emerald Innovations, Inc.. The institution of Prof. Katabi has received research support from Michael J Fox Foundation. The institution of Prof. Katabi has received research support from Rett Syndrome Research Trust. The institution of Prof. Katabi has received research support from Wistron. The institution of Prof. Katabi has received research support from Takeda. The institution of Prof. Katabi has received research support from Gwangju Institute of Science and Technology. The institution of Prof. Katabi has received research support from KACST . The institution of Prof. Katabi has received research support from IBM. |
Joanna Haas | Joanna Haas has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Vergegenomics . Joanna Haas has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nimbus Therapeutics . Joanna Haas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for X4 Pharmaceuticals. |
Rumen Hristov | Mr. Hristov has received personal compensation for serving as an employee of Emerald Innovations. Mr. Hristov has stock in Emerald Innovations. |
Pranav S. Krishna | Mr. Krishna has received personal compensation for serving as an employee of Emerald Innovations. Mr. Krishna has stock in Emerald Innovations. |
Rachel Levy, MS | Ms. Levy has stock in Emerald Innovations. |
Hariharan Rahul, PhD | Dr. Rahul has received personal compensation for serving as an employee of Emerald Innovations, Inc.. Dr. Rahul has stock in Emerald Innovations, Inc.. |
Shichao Yue | Dr. Yue has received personal compensation for serving as an employee of Emerald Innovation, Inc. |
Hardik Kothare, PhD | Dr. Kothare has received personal compensation for serving as an employee of Modality.AI, Inc.. Dr. Kothare has stock in Modality.AI, Inc.. |
Michael Neumann, PhD | Dr. Neumann has received personal compensation for serving as an employee of Modality.AI. Dr. Neumann has stock in Modality.AI. |
Meredith Bartlett, CCC-SLP | Ms. Bartlett has received personal compensation for serving as an employee of Modality.AI. |
Vikram Ramanarayanan, PhD | Dr. Ramanarayanan has received personal compensation for serving as an employee of Modality.AI, Inc. . Dr. Ramanarayanan has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Modality.AI, Inc. Dr. Ramanarayanan has stock in Modality.AI. The institution of Dr. Ramanarayanan has received research support from National Institutes of Health (NIH). Dr. Ramanarayanan has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with American Speech and Hearing Association (ASHA). |
Shane Raines | Shane Raines has received personal compensation for serving as an employee of Praxis Precision Medicines. Shane Raines has received personal compensation for serving as an employee of 2b Analytics. |
Grace I. Forde, MD | Dr. Forde has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. |
Atul T. Patel | Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN. |
Kenneth P. Martinez, MD | The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan. |
Angeli Mayadev, MD | Dr. Mayadev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mayadev has received research support from Ipsen. |
Ben Brucker, MD | Dr. Brucker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Dr. Brucker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic . Dr. Brucker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo pharma . The institution of Dr. Brucker has received research support from Abbvie. The institution of Dr. Brucker has received research support from Sumitomo pharma. |
Theodore R. Brown, MD | Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck. |
Ziyad Ayyoub, MD | Prof. Ayyoub has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Prof. Ayyoub has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ipsen. |
Rita Singh, PharmD | Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie. |
Mariana Nelson, PhD | Dr. Nelson has received personal compensation for serving as an employee of AbbVie. Dr. Nelson has stock in AbbVie Inc. |
Ahunna Ukah | Ahunna Ukah has received personal compensation for serving as an employee of AbbVie. Ahunna Ukah has stock in AbbVie. |
Irina Yushmanova, MD | Dr. Yushmanova has received personal compensation for serving as an employee of AbbVie. |
Simona Battucci, MD | Dr. Battucci has received personal compensation for serving as an employee of AbbVie . Dr. Battucci has stock in AbbVie . |
Kimberly Ifantides | Kimberly Ifantides has received personal compensation for serving as an employee of AbbVie. Kimberly Ifantides has stock in Abbvie. |
Christopher P. Rhyne, MD | Dr. Rhyne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. |
Merit E. Cudkowicz, MD, MSC, FAAN | Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care. |
Vivian E. Drory, MD | Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Drory has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight. |
Adriano Chio, MD, FAAN | Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. |
Christen L. Shoesmith, MD, BSc, FAAN | The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. The institution of Dr. Shoesmith has received research support from Neurosense. The institution of Dr. Shoesmith has received research support from Regeneron. Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to AAN interests or activities. |
Shiran Zimri, PhD | Dr. Zimri has nothing to disclose. |
Niva Russek- Blum, PhD | Dr. Russek- Blum has received personal compensation for serving as an employee of NeuroSense Therapeutics LTD.. Dr. Russek- Blum has stock in NeuroSense Therpeutics. |
Diana Shtossel | Miss Shtossel has nothing to disclose. |
Guy Shapira | Mr. Shapira has received intellectual property interests from a discovery or technology relating to health care. |
Noam Shomron, PhD | Prof. Shomron has nothing to disclose. |
Ferenc Tracik | Dr. Tracik has received personal compensation for serving as an employee of Neurosense Therapeutics. |
Jeffrey Rosenfeld, MD, PhD, FAAN | Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexion. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General. |
Jeremy M. Shefner, MD, PhD, FAAN | Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics. |
Alon Gorenshtein | Mr. Gorenshtein has nothing to disclose. |
Shiri Fistel, Msc | Mrs. Fistel has nothing to disclose. |
Moran Sorka, PhD | Mrs. Sorka has nothing to disclose. |
Raz Winer, MD | Dr. Winer has nothing to disclose. |
Shlomi Peretz, MD | Dr. Peretz has nothing to disclose. |
Shahar Shelly, MD | Dr. Shelly has stock in Remepy. |
Gregory J. Telman | No disclosure on file |
Dvir Aran, PhD | Dr. Aran has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Elevance Heatlh. Dr. Aran has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Link Cell Therapies. |
Eric Anderson, MD, PhD, FAAN | Dr. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sindler Law firm, WVU, MayerLLP, KBA attorneys. Dr. Anderson has stock in Synapticure. The institution of Dr. Anderson has received research support from NIH. |
Danielle Geraldi-Samara, MD | Dr. Geraldi-Samara has nothing to disclose. |
Elizabeth Ferluga, MD | Dr. Ferluga has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Ferluga has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. |
Noreen Flanagan, MD | Dr. Flanagan has nothing to disclose. |
Kevin H. Brendle | Mr. Brendle has nothing to disclose. |
Marc C. Patterson, MD, FRACP, FAAN | Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care. |
Jin-Tai Yu, PhD | Prof. Yu has nothing to disclose. |